Peter H. Killian
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Retinoids in leukemia and cellular processes 2
- Ubiquitin and proteasome pathways 1
- Histone Deacetylase Inhibitors Research 1
-
- Curcumin's Biomedical Applications 4
- Co-authors
- Beatrice E. Bachmeier (9 shared papers)Ulrich Pfeffer (7 shared papers)Emanuel Kronski (6 shared papers)Simonetta Astigiano (4 shared papers)Christian P. Sommerhoff (3 shared papers)Ottavia Barbieri (3 shared papers)Valentina Mirisola (4 shared papers)Dieter Melchart (1 shared paper)
- Journals
- Cancer Research (2 papers)Molecular Oncology (1 paper)Carcinogenesis (1 paper)Oncotarget (1 paper)PLoS ONE (1 paper)
- Partner nations
- GermanyItalyUnited Kingdom
In The Last Decade
Peter H. Killian
9 papers receiving 572 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 218
- Cancer Research 118
- Molecular Biology 306
- Biochemistry 26
- Pharmacology 34
Countries citing papers authored by Peter H. Killian
This map shows the geographic impact of Peter H. Killian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Killian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Killian more than expected).
Fields of papers citing papers by Peter H. Killian
This network shows the impact of papers produced by Peter H. Killian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Killian. The network helps show where Peter H. Killian may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter H. Killian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 143 | |
| 2 | 2014 | 141 | |
| 3 | 2018 | 69 | |
| 4 | 2011 | 68 | |
| 5 | 2010 | 66 | |
| 6 | 2009 | 53 | |
| 7 | 2016 | 31 | |
| 8 | 2011 | 6 | |
| 9 | 2013 | 3 |
About Peter H. Killian
Peter H. Killian is a scholar working on Molecular Biology, Molecular Medicine, Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 9 papers that have together received 580 indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (4 papers), Cancer Mechanisms and Therapy (2 papers), Retinoids in leukemia and cellular processes (2 papers), Ubiquitin and proteasome pathways (1 paper), NF-κB Signaling Pathways (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Chemokine receptors and signaling (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Molecular Medicine (218 citations), Cancer Research (118 citations), Molecular Biology (306 citations), Biochemistry (26 citations) and Pharmacology (34 citations). Peter H. Killian has collaborated with scholars based in Germany, Italy and United Kingdom. Frequent co-authors include Beatrice E. Bachmeier, Ulrich Pfeffer, Emanuel Kronski, Simonetta Astigiano, Christian P. Sommerhoff, Ottavia Barbieri, Valentina Mirisola, Dieter Melchart, Katharina Michalik and Thomas Efferth. Their work appears in journals such as Cancer Research, Molecular Oncology, Carcinogenesis, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.